Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycles™) product platform, announced that Chief Executive Officer Kevin Lee, Ph.D., will give a presentation at the “Delivery of Novel Therapies in the 21st Century”
October 17, 2018
· 2 min read